ArticleJournal of translational medicine2023

A bispecific antibody AP203 targeting PD-L1 and CD137 exerts potent antitumor activity without toxicity.

Po-Lin Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.